Immunosuppressive Macrophages Limit PARP Inhibitor Efficacy in TNBC

Article navigation

Research Watch| February 02 2021

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2020

American Association for Cancer Research.

Cancer Discov (2021) 11 (2): OF5.

Abstract

PARP inhibitor treatment increased tumor infiltration by immunosuppressive macrophages in vivo.

2020

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.